*Corresponding author:
Ana Luisa Pocas, Trainee in Psychiatry, Leiria's Hospital, PortugalReceived: April 09, 2018; Published: April 20, 2018
DOI: 10.26717/BJSTR.2018.04.000985
To view the Full Article Peer-reviewed Article PDF
Behavior disorders and psychosis can be a greater challenge for patients with dementia and their caregivers. Ninety percent of people with dementia experience behavioural and psychological symptoms such as aggression, agitation and psychosis. These symptoms can be distressing and a threat to the person and their caregivers. In these situations we always tend to medicate after suggesting non-pharmacological measures. The problem often arises after the symptomatology has been stabilized. There are evidence-based recommendations to assess psychological and behavioral symptoms of dementia and perform a risk/ benefit analysis before prescribing an antipsychotic. The Practice Guidelines of American Psychiatric Association (APA) includes recommendations with moderate/low strength of supporting research evidence concerning antipsychotic use to treat agitation or psychosis in patients with dementia [1,2].
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China